Howard J Huang1, Warren Isakow1, Derek E Byers1, Jacquelyn T Engle2, Elizabeth A Griffin2, Debra Kemp3, Steven L Brody4, Robert J Gropler2, J Philip Miller5, Wenhua Chu2, Dong Zhou2, Richard A Pierce1, Mario Castro1, Robert H Mach2, Delphine L Chen6. 1. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri. 2. Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri. 3. Center for Clinical Studies, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri; and. 4. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri. 5. Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri. 6. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri chend@mir.wustl.edu.
Abstract
UNLABELLED: Inducible nitric oxide synthase (iNOS) activity increases in acute and chronic inflammatory lung diseases. Imaging iNOS expression may be useful as an inflammation biomarker for monitoring lung disease activity. We developed a novel tracer for PET that binds to iNOS in vivo, (18)F-NOS. In this study, we tested whether (18)F-NOS could quantify iNOS expression from endotoxin-induced lung inflammation in healthy volunteers. METHODS: Healthy volunteers were screened to exclude cardiopulmonary disease. Qualifying volunteers underwent a baseline, 1-h dynamic (18)F-NOS PET/CT scan. Endotoxin (4 ng/kg) was then instilled bronchoscopically in the right middle lobe. (18)F-NOS imaging was performed again approximately 16 h after endotoxin instillation. Radiolabeled metabolites were determined from blood samples. Cells recovered by bronchoalveolar lavage (BAL) after imaging were stained immunohistochemically for iNOS. (18)F-NOS uptake was quantified as the distribution volume ratio (DVR) determined by Logan plot graphical analysis in volumes of interest placed over the area of endotoxin instillation and in an equivalent lung region on the left. The mean Hounsfield units (HUs) were also computed using the same volumes of interest to measure density changes. RESULTS: Seven healthy volunteers with normal pulmonary function completed the study with evaluable data. The DVR increased by approximately 30%, from a baseline mean of 0.42 ± 0.07 to 0.54 ± 0.12, and the mean HUs by 11% after endotoxin in 6 volunteers who had positive iNOS staining in BAL cells. The DVR did not change in the left lung after endotoxin. In 1 volunteer with low-level iNOS staining in BAL cells, the mean HUs increased by 7% without an increase in DVR. Metabolism was rapid, with approximately 50% of the parent compound at 5 min and 17% at 60 min after injection. CONCLUSION: (18)F-NOS can be used to image iNOS activity in acute lung inflammation in humans and may be a useful PET tracer for imaging iNOS expression in inflammatory lung disease.
UNLABELLED: Inducible nitric oxide synthase (iNOS) activity increases in acute and chronic inflammatory lung diseases. Imaging iNOS expression may be useful as an inflammation biomarker for monitoring lung disease activity. We developed a novel tracer for PET that binds to iNOS in vivo, (18)F-NOS. In this study, we tested whether (18)F-NOS could quantify iNOS expression from endotoxin-induced lung inflammation in healthy volunteers. METHODS: Healthy volunteers were screened to exclude cardiopulmonary disease. Qualifying volunteers underwent a baseline, 1-h dynamic (18)F-NOS PET/CT scan. Endotoxin (4 ng/kg) was then instilled bronchoscopically in the right middle lobe. (18)F-NOS imaging was performed again approximately 16 h after endotoxin instillation. Radiolabeled metabolites were determined from blood samples. Cells recovered by bronchoalveolar lavage (BAL) after imaging were stained immunohistochemically for iNOS. (18)F-NOS uptake was quantified as the distribution volume ratio (DVR) determined by Logan plot graphical analysis in volumes of interest placed over the area of endotoxin instillation and in an equivalent lung region on the left. The mean Hounsfield units (HUs) were also computed using the same volumes of interest to measure density changes. RESULTS: Seven healthy volunteers with normal pulmonary function completed the study with evaluable data. The DVR increased by approximately 30%, from a baseline mean of 0.42 ± 0.07 to 0.54 ± 0.12, and the mean HUs by 11% after endotoxin in 6 volunteers who had positive iNOS staining in BAL cells. The DVR did not change in the left lung after endotoxin. In 1 volunteer with low-level iNOS staining in BAL cells, the mean HUs increased by 7% without an increase in DVR. Metabolism was rapid, with approximately 50% of the parent compound at 5 min and 17% at 60 min after injection. CONCLUSION: (18)F-NOS can be used to image iNOS activity in acute lung inflammation in humans and may be a useful PET tracer for imaging iNOS expression in inflammatory lung disease.
Authors: N P O'Grady; H L Preas; J Pugin; C Fiuza; M Tropea; D Reda; S M Banks; A F Suffredini Journal: Am J Respir Crit Care Med Date: 2001-06 Impact factor: 21.405
Authors: Fabio L M Ricciardolo; Gaetano Caramori; Kazuhiro Ito; Armando Capelli; Paola Brun; Giovanni Abatangelo; Alberto Papi; Kian Fan Chung; Ian Adcock; Peter J Barnes; Claudio F Donner; Andrea Rossi; Antonino Di Stefano Journal: J Allergy Clin Immunol Date: 2005-09-28 Impact factor: 10.793
Authors: C Sittipunt; K P Steinberg; J T Ruzinski; C Myles; S Zhu; R B Goodman; L D Hudson; S Matalon; T R Martin Journal: Am J Respir Crit Care Med Date: 2001-02 Impact factor: 21.405
Authors: Delphine L Chen; Thomas W Ferkol; Mark A Mintun; Jessica E Pittman; Daniel B Rosenbluth; Daniel P Schuster Journal: Am J Respir Crit Care Med Date: 2006-03-16 Impact factor: 21.405
Authors: Dong Zhou; Hsiaoju Lee; Justin M Rothfuss; Delphine L Chen; Datta E Ponde; Michael J Welch; Robert H Mach Journal: J Med Chem Date: 2009-04-23 Impact factor: 7.446
Authors: Deepak R Subramanian; Lee Jenkins; Ross Edgar; Nabil Quraishi; Robert A Stockley; David G Parr Journal: Am J Respir Crit Care Med Date: 2012-07-26 Impact factor: 21.405
Authors: Catherine A Foss; Donika Plyku; Alvaro A Ordonez; Julian Sanchez-Bautista; Hailey B Rosenthal; Il Minn; Martin A Lodge; Martin G Pomper; George Sgouros; Sanjay K Jain Journal: J Nucl Med Date: 2018-04-26 Impact factor: 10.057
Authors: Antonio Pesenti; Guido Musch; Daniel Lichtenstein; Francesco Mojoli; Marcelo B P Amato; Gilda Cinnella; Luciano Gattinoni; Michael Quintel Journal: Intensive Care Med Date: 2016-03-31 Impact factor: 17.440
Authors: Kornelis S M van der Geest; Maria Sandovici; Pieter H Nienhuis; Riemer H J A Slart; Peter Heeringa; Elisabeth Brouwer; William F Jiemy Journal: Front Med (Lausanne) Date: 2022-06-06
Authors: Jing Wu; Nabil E Boutagy; Zhengxin Cai; Shu-Fei Lin; Ming-Qiang Zheng; Attila Feher; John C Stendahl; Michael Kapinos; Jean-Dominique Gallezot; Hui Liu; Tim Mulnix; Wenjie Zhang; Marcel Lindemann; Jo-Ku Teng; Edward J Miller; Yiyun Huang; Richard E Carson; Albert J Sinusas; Chi Liu Journal: J Nucl Cardiol Date: 2020-05-15 Impact factor: 5.952